These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 31594404)

  • 1. Structure and development of single domain antibodies as modules for therapeutics and diagnostics.
    Hoey RJ; Eom H; Horn JR
    Exp Biol Med (Maywood); 2019 Dec; 244(17):1568-1576. PubMed ID: 31594404
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Introduction to heavy chain antibodies and derived Nanobodies.
    Vincke C; Muyldermans S
    Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Applications and challenges in designing VHH-based bispecific antibodies: leveraging machine learning solutions.
    Mullin M; McClory J; Haynes W; Grace J; Robertson N; van Heeke G
    MAbs; 2024; 16(1):2341443. PubMed ID: 38666503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress in nanobody and its application in diagnosis].
    Kong Q; Yao Y; Chen R; Lu S
    Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nanobodies: natural single-domain antibodies.
    Muyldermans S
    Annu Rev Biochem; 2013; 82():775-97. PubMed ID: 23495938
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.
    Arbabi-Ghahroudi M
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563400
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Physicochemical improvement of rabbit derived single-domain antibodies by substitutions with amino acids conserved in camelid antibodies.
    Shinozaki N; Hashimoto R; Noda M; Uchiyama S
    J Biosci Bioeng; 2018 Jun; 125(6):654-661. PubMed ID: 29398547
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural Basis of Epitope Recognition by Heavy-Chain Camelid Antibodies.
    Zavrtanik U; Lukan J; Loris R; Lah J; Hadži S
    J Mol Biol; 2018 Oct; 430(21):4369-4386. PubMed ID: 30205092
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional mutations in and characterization of VHH against Helicobacter pylori urease.
    Hoseinpoor R; Mousavi Gargari SL; Rasooli I; Rajabibazl M; Shahi B
    Appl Biochem Biotechnol; 2014 Mar; 172(6):3079-91. PubMed ID: 24492955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular recognition requires dimerization of a VHH antibody.
    Smith CA; Sonneson GJ; Hoey RJ; Hinerman JM; Sheehy K; Walter R; Herr AB; Horn JR
    MAbs; 2023; 15(1):2215363. PubMed ID: 37243579
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
    Liu B; Yang D
    Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utilizing nanobody technology to target non-immunodominant domains of VAR2CSA.
    Ditlev SB; Florea R; Nielsen MA; Theander TG; Magez S; Boeuf P; Salanti A
    PLoS One; 2014; 9(1):e84981. PubMed ID: 24465459
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Two-Step Approach for the Design and Generation of Nanobodies.
    Wagner HJ; Wehrle S; Weiss E; Cavallari M; Weber W
    Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30400198
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Biophysical and biochemical characterization of a VHH-based IgG-like bi- and trispecific antibody platform.
    Pekar L; Busch M; Valldorf B; Hinz SC; Toleikis L; Krah S; Zielonka S
    MAbs; 2020; 12(1):1812210. PubMed ID: 32887531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of a camelid derived antibody targeting a linear epitope in the hinge domain of human PCSK9 protein.
    Li X; Hong J; Gao X; Wang M; Yang N
    Sci Rep; 2022 Jul; 12(1):12211. PubMed ID: 35842473
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Production of Designer VHH-Based Antibodies in Plants.
    De Greve H
    Methods Mol Biol; 2022; 2446():205-230. PubMed ID: 35157275
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Single domain camel antibodies: current status.
    Muyldermans S
    J Biotechnol; 2001 Jun; 74(4):277-302. PubMed ID: 11526908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Biochemistry, structure, and cellular internalization of a four nanobody-bearing Fc dimer.
    Chabrol E; Fagnen C; Landron S; Marcheteau E; Stojko J; Guenin SP; Antoine M; Fould B; Ferry G; Boutin JA; Vénien-Bryan C
    Protein Sci; 2021 Sep; 30(9):1946-1957. PubMed ID: 34117809
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Perspectives for the Development of CD38-Specific Heavy Chain Antibodies as Therapeutics for Multiple Myeloma.
    Bannas P; Koch-Nolte F
    Front Immunol; 2018; 9():2559. PubMed ID: 30459772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanobody‑horseradish peroxidase and -EGFP fusions as reagents to detect porcine parvovirus in the immunoassays.
    Lu Q; Li X; Zhao J; Zhu J; Luo Y; Duan H; Ji P; Wang K; Liu B; Wang X; Fan W; Sun Y; Zhou EM; Zhao Q
    J Nanobiotechnology; 2020 Jan; 18(1):7. PubMed ID: 31910833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.